Treating the Whole Patient: Exploring the Healing Potential of a Mind-Body Approach to Mental Health. Questo articolo non è disponibile.Treating the Whole Patient: Exploring the Healing Potential of a Mind-Body Approach to Mental Health

Treating the Whole Patient: Exploring the Healing Potential of a Mind-Body Approach to Mental Health promotes a shift in patient care that encourages healthcare professionals to move beyond a one-dimensional approach to the management of a disease toward a multi-dimensional approach that incorporates new scientific understandings of the many connections between mind and body relevant to diagnosing, treating, and managing patients with psychiatric disorders. Our ultimate goal is to provide an understanding of the neurobiology of a disease and its effect on a patient, consider the role of medical comorbidities on the psychiatric disorder, learn strategies for successful treatment and management options, address barriers to care, and better comprehend the impact of wellness on mental health. Based on cutting-edge scientific data in fields as diverse as neuroscience, genetics and immunology, Treating the Whole Patient: Exploring the Healing Potential of a Mind-Body Approach to Mental Health demonstrate through a question and answer format how recent discoveries promote an integrated mind-body perspective on psychiatric illness that will empower healthcare professionals to optimize therapeutic outcomes by improving multiple aspects of patient care with the long-term result of helping individuals suffering from psychiatric disease to attain wellness. The Treating the Whole Patient mental health initiatives are provided by CME LLC and encompass not only the ongoing community forum of blog posts but also live regional meetings as well as a series of educational sessions at the annual U.S. Psychiatric and Mental Health Congress. To view new blogs on this emerging approach to mental health care or find out more information on these initiatives, visit www.cmellc.com/Home/TreatingtheWholePatient.

Jon W. Draud, MS, MD Medical Director of Psychiatry, Addiction Medicine Services, Baptist Hospital, Nashville, TN, and Middle Tennessee Medical Center, Murfreesboro, TN; Private Practice, Adult and Adolescent Psychiatry Dr. Draud has been involved in design and implementation of several neurobiology projects, including depression, bipolar disorder, insomnia, and pain, with an emphasis on fibromyalgia and neuropathic pain. He was recently appointed by the MJ Consulting Group to its Neuroscience Advisory Council and is one of the founding members of the Integrative Neurobiology Educational Institute. Rakesh Jain, MD, MPH Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, TX; Associate Clinical Professor, Department of Psychiatry and Behavioral Sciences, University of Texas Medical School at Houston, Houston, TX Dr. Jain is involved in multiple research projects studying the effects of medications on short-term and long-term treatment of depression, anxiety, pain/mood overlap disorders, and psychosis in adult and child/adolescent populations. He also authored of several articles on the issue of mood and pain conditions. Vladimir Maletic, MS, MD Clinical Professor of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, SC; Consulting Associate, Division of Child and Adolescent Psychiatry, Department of Psychiatry, Duke University, Durham, NC Dr. Maletic has published numerous articles and has participated in various national and international meetings and congresses. His special areas of interest include neurobiology of mood disorders, pain, anxiety disorders, ADHD, and regulation of sleep and wakefulness. Charles Raison, MD Associate Professor, Department of Psychiatry, University of Arizona College of Medicine; John & Doris Norton School of Family and Consumer Sciences, University of Arizona, Tucson, AZ. Recipient of several teaching awards, Dr. Raison's research focuses on bi-directional relationships between stress and immune systems as these relate to the development of depression. His research ranges from immune system effects on central nervous system functioning to the application of compassion meditation as a strategy to reduce inflammatory responses to psychosocial stress. Dr. Raison is also on the editorial board of Brain, Behavior and Immunity.